RATNAKAR PAI: Open Payments
NPI 1740296045 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 18 payments from 7 companies in 2025. Trend: 2023 $167 · 2024 $168 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $157 |
| Neurocrine BioSciences, Inc. | 1 | $124 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Vanda Pharmaceuticals Inc. | 5 | $104 |
| Luye Pharma (USA) Ltd. | 1 | $71 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: INVEGA SUSTENNA, INGREZZA, COBENFY, FANAPT, ERZOFRI EXTENDED-RELEASE, ABILIFY MAINTENA, UZEDY.
Industry payments across MI — which companies pay providers there.
